Literature DB >> 29391601

The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim.

Lazaro E Aira1, Elodie Villa1, Pascal Colosetti1, Parvati Gamas1, Laurie Signetti1, Sandrine Obba1, Emma Proics1, Fabien Gautier2,3, Béatrice Bailly-Maitre1, Arnaud Jacquel1, Guillaume Robert1, Frédéric Luciano1, Philippe P Juin2,3, Jean-Ehrland Ricci1, Patrick Auberger1, Sandrine Marchetti4.   

Abstract

Phosphorylation of Ser/Thr residues is a well-established modulating mechanism of the pro-apoptotic function of the BH3-only protein Bim. However, nothing is known about the putative tyrosine phosphorylation of this Bcl-2 family member and its potential impact on Bim function and subsequent Bax/Bak-mediated cytochrome c release and apoptosis. As we have previously shown that the tyrosine kinase Lyn could behave as an anti-apoptotic molecule, we investigated whether this Src family member could directly regulate the pro-apoptotic function of Bim. In the present study, we show that Bim is phosphorylated onto tyrosine residues 92 and 161 by Lyn, which results in an inhibition of its pro-apoptotic function. Mechanistically, we show that Lyn-dependent tyrosine phosphorylation of Bim increases its interaction with anti-apoptotic members such as Bcl-xL, therefore limiting mitochondrial outer membrane permeabilization and subsequent apoptosis. Collectively, our data uncover one molecular mechanism through which the oncogenic tyrosine kinase Lyn negatively regulates the mitochondrial apoptotic pathway, which may contribute to the transformation and/or the chemotherapeutic resistance of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29391601     DOI: 10.1038/s41388-017-0112-0

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

1.  An absolute requirement for Fyn in T cell receptor-induced caspase activation and apoptosis.

Authors:  J E Ricci; V Lang; F Luciano; N Belhacene; V Giordanengo; F Michel; G Bismuth; P Auberger
Journal:  FASEB J       Date:  2001-08       Impact factor: 5.191

2.  Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo.

Authors:  C Clybouw; D Merino; T Nebl; F Masson; M Robati; L O'Reilly; A Hübner; R J Davis; A Strasser; P Bouillet
Journal:  Cell Death Differ       Date:  2012-01-13       Impact factor: 15.828

Review 3.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

4.  Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia.

Authors:  Francesca Zonta; Mario Angelo Pagano; Livio Trentin; Elena Tibaldi; Federica Frezzato; Cristina Gattazzo; Veronica Martini; Valentina Trimarco; Marco Mazzorana; Luciana Bordin; Gianpietro Semenzato; Anna Maria Brunati
Journal:  Blood       Date:  2013-12-18       Impact factor: 22.113

5.  Multisite phosphorylation regulates Bim stability and apoptotic activity.

Authors:  Anette Hübner; Tamera Barrett; Richard A Flavell; Roger J Davis
Journal:  Mol Cell       Date:  2008-05-23       Impact factor: 17.970

6.  Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance.

Authors:  Jessie Pécot; Laurent Maillet; Janic Le Pen; Céline Vuillier; Sophie de Carné Trécesson; Aurélie Fétiveau; Kristopher A Sarosiek; Florian J Bock; Frédérique Braun; Anthony Letai; Stephen W G Tait; Fabien Gautier; Philippe P Juin
Journal:  Cell Rep       Date:  2016-12-20       Impact factor: 9.423

7.  Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.

Authors:  Cinta Mestre-Escorihuela; Fanny Rubio-Moscardo; Jose A Richter; Reiner Siebert; Joan Climent; Vicente Fresquet; Elena Beltran; Xabier Agirre; Isabel Marugan; Miguel Marín; Andreas Rosenwald; Kei-Ji Sugimoto; Luise M Wheat; E Loraine Karran; Juan F García; Lydia Sanchez; Felipe Prosper; Louis M Staudt; Daniel Pinkel; Martin J S Dyer; Jose A Martinez-Climent
Journal:  Blood       Date:  2006-09-07       Impact factor: 22.113

8.  Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover.

Authors:  Rebecca Ley; Katherine E Ewings; Kathryn Hadfield; Elizabeth Howes; Kathryn Balmanno; Simon J Cook
Journal:  J Biol Chem       Date:  2003-12-17       Impact factor: 5.157

9.  HER2 phosphorylates and destabilizes pro-apoptotic PUMA, leading to antagonized apoptosis in cancer cells.

Authors:  Richard L Carpenter; Woody Han; Ivy Paw; Hui-Wen Lo
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

10.  Imatinib and nilotinib induce apoptosis of chronic myeloid leukemia cells through a Bim-dependant pathway modulated by cytokines.

Authors:  Francis Belloc; François Moreau-Gaudry; Maialen Uhalde; Laurie Cazalis; Marie Jeanneteau; Francis Lacombe; Vincent Praloran; François-Xavier Mahon
Journal:  Cancer Biol Ther       Date:  2007-03-05       Impact factor: 4.742

View more
  3 in total

1.  Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells.

Authors:  Giusy Tornillo; Catherine Knowlson; Howard Kendrick; Joe Cooke; Hasan Mirza; Iskander Aurrekoetxea-Rodríguez; Maria D M Vivanco; Niamh E Buckley; Anita Grigoriadis; Matthew J Smalley
Journal:  Cell Rep       Date:  2018-12-26       Impact factor: 9.423

Review 2.  In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs.

Authors:  Zarko Gagic; Dusan Ruzic; Nemanja Djokovic; Teodora Djikic; Katarina Nikolic
Journal:  Front Chem       Date:  2020-01-08       Impact factor: 5.221

3.  Three Potential Tumor Markers Promote Metastasis and Recurrence of Colorectal Cancer by Regulating the Inflammatory Response: ADAM8, LYN, and S100A9.

Authors:  Jiawei Liu; Jing Li; Haolin Du; Liming Xu; Zhenbang Yang; Mengjiao Yuan; Kaiyue Zhang; Jialei Li; Wenjun Xing; Shoujie Wang; Tingting Hu; Jinjin Wang; Jin Wang; Qian Gong
Journal:  Comput Math Methods Med       Date:  2022-01-22       Impact factor: 2.238

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.